ストックスクリーナーアプリを入手
22.57
0.18%
-0.04
アフターアワーズ：
22.55
-0.02
-0.09%
前日終値:
$22.61
開ける：
$22.82
24時間の取引高:
2.03M
Relative Volume:
1.18
時価総額：
$1.44B
収益：
-
当期純損益:
$-107.85M
株価収益率:
-10.21
EPS:
-2.21
ネットキャッシュフロー:
$-106.82M
1週間 パフォーマンス:
+4.78%
1か月 パフォーマンス:
+1.26%
6か月 パフォーマンス:
-21.03%
1年 パフォーマンス:
-42.31%
1日の値動き範囲:
$22.41
$23.81
1週間の範囲:
$21.20
$23.81
52週間の値動き範囲:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
名前
Vera Therapeutics Inc
セクター
電話
650-770-0077
住所
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
22.57 | 1.39B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-04 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2025-01-28 | 開始されました | Goldman | Buy |
| 2024-11-21 | 開始されました | Wells Fargo | Overweight |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-01-25 | 開始されました | Oppenheimer | Outperform |
| 2024-01-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 開始されました | Raymond James | Outperform |
| 2023-11-10 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-16 | 開始されました | Guggenheim | Buy |
| 2023-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-04 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-07-12 | 開始されました | JP Morgan | Overweight |
| 2022-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2022-04-19 | 開始されました | Wedbush | Outperform |
すべてを表示
Vera Therapeutics Inc (VERA) 最新ニュース
Strategies to average down on Vera Therapeutics Inc.2025 Market Outlook & Proven Capital Preservation Tips - Newser
Long term hold vs stop loss in Vera Therapeutics Inc.2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser
What data driven models say about Vera Therapeutics Inc.’s futureJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Vera Therapeutics Inc. stock prediction for this weekTrade Risk Report & AI Enhanced Trade Execution Alerts - Newser
Intraday pattern recognizer results for Vera Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Reversal indicators forming on Vera Therapeutics Inc. stockJuly 2025 Levels & Proven Capital Preservation Tips - Newser
Chart based analysis of Vera Therapeutics Inc. trendsJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Can momentum traders help lift Vera Therapeutics Inc.July 2025 Big Picture & Trade Opportunity Analysis - Newser
What institutional flow reveals about Vera Therapeutics Inc.Rate Hike & Precise Swing Trade Entry Alerts - Newser
Using flow based indicators on Vera Therapeutics Inc.Weekly Stock Recap & Growth Focused Entry Point Reports - Newser
When is the best time to exit Vera Therapeutics Inc.Earnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Can Vera Therapeutics’ (VERA) Widening Losses Challenge Its Path to Sustainable Growth? - Yahoo Finance
Pattern recognition hints at Vera Therapeutics Inc. upsideJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How sentiment analysis helps forecast Vera Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - Newser
Is This a Bottoming Phase for Vera Therapeutics Inc.July 2025 Outlook & AI Driven Stock Movement Reports - metrotimes.co.kr
Measuring Vera Therapeutics Inc.’s beta against major indices2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Can Vera Therapeutics Inc. stock recover from recent declineMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionMarket Sentiment Review & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-17 09:44:14 - metal.it
Will a bounce in Vera Therapeutics Inc. offer an exitQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy Trends2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
What’s next for Vera Therapeutics Inc. stock price2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Should I average down on Vera Therapeutics Inc. stockMarket Sentiment Report & Stock Market Timing Techniques - newsyoung.net
Vera Therapeutics Inc. Stock Performance After Earnings: Historical InsightsGold Moves & Free Safe Entry Trade Signal Reports - Newser
Vera Therapeutics shares fall 2.84% premarket after announcing inducement grants to new employees. - AInvest
Is Vera Therapeutics Inc. stock a hidden gemSmart Portfolio Allocation - thegnnews.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 - MarketScreener
10,496 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by XTX Topco Ltd - Defense World
Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
What makes Vera Therapeutics Inc. stock price move sharplyFree Portfolio Health Check - thegnnews.com
How to recover losses in Vera Therapeutics Inc. stockFree Investment Plan With Growth Optimization - Newser
JPMorgan Chase & Co. Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $53.00 - Defense World
Custom watchlist performance reports with Vera Therapeutics Inc.Portfolio Safety Metrics and Return Analysis - Newser
Vera Therapeutics: Equity Incentives and BLA Timelines Signal Confidence in Value Creation - AInvest
HC Wainwright Analysts Lower Earnings Estimates for VERA - Defense World
Lifesci Capital Has Negative Estimate for VERA Q3 Earnings - Defense World
Cantor Fitzgerald Issues Negative Forecast for VERA Earnings - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
Vera Therapeutics Inc. stock daily chart insightsTrade Ideas Based on Fundamental Metrics - Newser
Vera Therapeutics Awards Major Stock Package: 99,000 Options, 48,200 RSUs to Expand Team - Stock Titan
Wedbush Research Analysts Reduce Earnings Estimates for VERA - Defense World
Vera Therapeutics (VERA) to Release Quarterly Earnings on Thursday - Defense World
Can volume confirm reversal in Vera Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Vera Therapeutics Advances Clinical Trials and Financials Amid Progress Toward Commercial Launch - AInvest
Vera Therapeutics Q2 Net Loss Doubles, Revenue at $76.5 Million - AInvest
Vera (VERA) Q2 Net Loss Widens 127% - The Motley Fool
Vera Therapeutics Reports Progress in Clinical Trials - TipRanks
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $85 - 富途牛牛
Bkv Corporation shares rise 1.82% after-hours following Vera Therapeutics' positive trial results and upcoming BLA submission. - AInvest
Vera Therapeutics Signs New Sales Agreement with TD Securities - TipRanks
Vera Therapeutics Inc (VERA) 財務データ
収益
当期純利益
現金流量
EPS
Vera Therapeutics Inc (VERA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):